中国 EN 400-660-9091

联系我们

电话:025-68037686

地址:江苏生命科技创新园F6幢1层

订购:nanjing03@biogot.com

服务:biorase01@biogot.com

合作:lvyun@biogot.com

支持:may@biogot.com

Bioworld引用文献(23852),当前文献数据更新至2024年12月31日

  • DNA damage checkpoint pathway modulates the regulation of skeletal growth and osteoblastic bone formation by parathyroid hormone-related peptide
    Journal: International Journal of Biological Sciences 引用产品:Anti-β-actin antibody(AP0060/BS6007M)
    ApplicationWB
    IF4.858
    SpeciesMouse
  • Berberine suppresses apoptosis and extracellular matrix (ECM) degradation in nucleus pulposus cells and ameliorates disc degeneration in a rodent model
    Journal: International Journal of Biological Sciences 引用产品:FITC-labeled secondary antibodies(BS10000)
    ApplicationICC
    IF4.858
    SpeciesHuman
  • Berberine suppresses apoptosis and extracellular matrix (ECM) degradation in nucleus pulposus cells and ameliorates disc degeneration in a rodent model
    Journal: International Journal of Biological Sciences 引用产品:horseradish peroxidase-labeled secondary antibodies(BS13278)
    ApplicationWB
    IF4.858
    SpeciesHuman
  • Glibenclamide Targets Sulfonylurea Receptor 1 to Inhibit p70S6K Activity and Upregulate KLF4 Expression to Suppress Non-Small Cell Lung Carcinoma
    Journal: Molecular Cancer Therapeutics 引用产品:anti-β-actin antibody(BS6007)
    ApplicationWB
    IF4.856
    SpeciesHuman
  • Glibenclamide Targets Sulfonylurea Receptor 1 to Inhibit p70S6K Activity and Upregulate KLF4 Expression to Suppress Non-Small Cell Lung Carcinoma
    Journal: Molecular Cancer Therapeutics 引用产品:anti-GAPDH antibody(AP0063)
    ApplicationWB
    IF4.856
    SpeciesHuman
  • Glibenclamide Targets Sulfonylurea Receptor 1 to Inhibit p70S6K Activity and Upregulate KLF4 Expression to Suppress Non-Small Cell Lung Carcinoma
    Journal: Molecular Cancer Therapeutics 引用产品:anti-HA antibody(AP0005M)
    ApplicationWB
    IF4.856
    SpeciesHuman
  • Glibenclamide Targets Sulfonylurea Receptor 1 to Inhibit p70S6K Activity and Upregulate KLF4 Expression to Suppress Non-Small Cell Lung Carcinoma
    Journal: Molecular Cancer Therapeutics 引用产品:anti-flag antibody(AP0007M)
    ApplicationWB
    IF4.856
    SpeciesHuman
  • Glibenclamide Targets Sulfonylurea Receptor 1 to Inhibit p70S6K Activity and Upregulate KLF4 Expression to Suppress Non-Small Cell Lung Carcinoma
    Journal: Molecular Cancer Therapeutics 引用产品:anti-E-cadherin antibody(BS1098)
    ApplicationWB
    IF4.856
    SpeciesHuman
  • Glibenclamide Targets Sulfonylurea Receptor 1 to Inhibit p70S6K Activity and Upregulate KLF4 Expression to Suppress Non-Small Cell Lung Carcinoma
    Journal: Molecular Cancer Therapeutics 引用产品:anti-N-cadherin antibody(BS2224)
    ApplicationWB
    IF4.856
    SpeciesHuman
  • Combining DNA Vaccine and AIM2 in H1 Nanoparticles Exert Anti-Renal Carcinoma Effects via Enhancing Tumor-Specific Multi-functional CD8+ T-cell Responses
    Journal: Molecular Cancer Therapeutics 引用产品:cDNA()
    Application
    IF4.856
    Species

关注我们

400-660-9091

电话:025-68037686

地址:江苏生命科技创新园F6幢1层

订购:nanjing03@biogot.com

服务:biorase01@biogot.com

合作:lvyun@biogot.com

支持:may@biogot.com